WINDLAS BIOTECH
Back to Income Statement
|
WINDLAS BIOTECH Last 5 Year Revenue History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Sales | ₹631 Cr | ₹513 Cr | ₹466 Cr | ₹428 Cr | ₹329 Cr |
What is the latest Revenue of WINDLAS BIOTECH ?
Year | Revenue |
---|---|
Mar2024 | ₹631 Cr |
Mar2023 | ₹513 Cr |
Mar2022 | ₹466 Cr |
Mar2021 | ₹428 Cr |
Mar2020 | ₹329 Cr |
How is Revenue of WINDLAS BIOTECH Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2024 | ₹631 Cr | 22.97 | |
Mar2023 | ₹513 Cr | 10.12 | |
Mar2022 | ₹466 Cr | 8.96 | |
Mar2021 | ₹428 Cr | 30.03 | |
Mar2020 | ₹329 Cr | - |
Compare Revenue of peers of WINDLAS BIOTECH
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
WINDLAS BIOTECH | ₹2,067.0 Cr | -5.5% | 11.1% | 85.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹410,142.0 Cr | -1.5% | 9.1% | 9.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹145,762.0 Cr | -4.9% | -0.6% | 59.1% | Stock Analytics | |
CIPLA | ₹114,322.0 Cr | -1.8% | 1% | 0.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹111,171.0 Cr | 1.6% | 12.1% | 21.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹92,603.7 Cr | -3% | -0.9% | -7.7% | Stock Analytics |
WINDLAS BIOTECH Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
WINDLAS BIOTECH | -5.5% |
11.1% |
85.3% |
SENSEX | -2.9% |
3.1% |
1.8% |
You may also like the below Video Courses